Engaging Community Pharmacists in Improving Treatment Outcomes for Patients with Opioid Use Disorder
September 24, 2024Today, the National Association of Boards of Pharmacy and the National Community Pharmacists Association will begin distributing a first-of-its-kind practice guideline to the nation’s 60,000...
Webinar
Webinar: Impact of the End of the COVID-19 Public Health Emergency on Opioid Use Disorder Treatment (5/16/2023)
April 27, 2023The federal Public Health Emergency for COVID-19 (PHE) has transformed dramatically the landscape for opioid use disorder and other drug...
President’s Update
President’s Update, Apr. ’23: Learning from Our Grantees as We Launch New Programs
April 25, 2023As I read through FORE’s latest Annual Report, I’m struck by the real-world impacts we’re making and insights we’re gaining...
FORE Announcements
FORE’s New Annual Report: Measuring Impacts and Launching New Strategies
April 11, 2023We are excited to share our new Annual Report, which describes how we’re pursuing our mission to inspire and accelerate...
Program Brief
New Issue Brief Explores How COVID-Era Flexibilities Affected Opioid Use Disorder Treatment
April 05, 2023To sustain access to treatment for opioid use disorder (OUD) during the coronavirus pandemic, federal policymakers changed some of the...
FORE Announcements
New FORE Grants Support Community-Based Organizations Combatting the Opioid Use Disorder and Overdose Crisis
March 29, 2023Today FORE announced $2.2 million in new grants to community-based organizations (CBOs) that offer harm reduction, prevention, treatment, and recovery...
Program Brief
New FORE Brief Focuses on Expanding Access to MOUD Treatment During and After Incarceration
March 23, 2023In late January, the Biden Administration approved an amendment to California’s Section 1115 waiver, enabling the state’s Medicaid program to...